SCHEMBL4930253

SCHEMBL4930253

c1coc(-c2ccnn3ccnc23)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.41
KDM4E B2RXH2 8/20 0.41
ALDH1A1 P00352 6/20 0.41
RCE1 Q9Y256 1/20 0.41
MAPK1 P28482 1/20 0.41
BMP4 P12644 1/20 0.40
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
FYN P06241 1/20 0.38
POLB P06746 3/20 0.38
MAPT P10636 2/20 0.38
BLM P54132 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
USP2 O75604 1/20 0.38
LMNA P02545 1/20 0.38
THRB P10828 1/20 0.38
PKM P14618 1/20 0.38
HPGD P15428 1/20 0.38
ALOX15 P16050 1/20 0.38
ALOX12 P18054 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4920355 0.78 HSD17B10 (0.40) HSD17B10KDM4EALDH1A1RCE1MAPK1
SCHEMBL11156058 0.75 DNMT1 (0.42) HSD17B10KDM4EALDH1A1RCE1MEN1
SCHEMBL1202802 0.73 CDK2 (0.45) BMP4MEN1KMT2ANPC1RAB9A
SCHEMBL15473570 0.69 CYP17A1 (0.46) KDM4EALDH1A1BMP4MEN1KMT2A
SCHEMBL12970192 0.69 CCNE1 (0.47) BMP4ADORA2AADORA1
SCHEMBL19305216 0.69 BMP4 (0.38) BMP4
SCHEMBL3357416 0.68 BMP4 (0.39) BMP4
SCHEMBL19305220 0.68 ADORA2A (0.44) HSD17B10KDM4EALDH1A1MAPK1BMP4
SCHEMBL25149671 0.67 BMP4 (0.39) BMP4
SCHEMBL15473779 0.67 GRIN2B (0.36) BMP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080219922-A1 Alzheimer's Disease Imaging Agents EMORY UNIVERSITY 2008-09-11 US disclosed
WO-2007033080-A2 ALZHEIMER'S DISEASE IMAGING AGENTS EMORY UNIVERSITY (US) 2007-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080219922-A1 Alzheimer's Disease Imaging Agents APP, PSEN1, MAPT HSD17B10 3256/4885KDM4E 4201/4885ALDH1A1 4251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.